Literature DB >> 1420597

Selective species specificity of tumor necrosis factor for toxicity in the mouse.

P Brouckaert1, C Libert, B Everaerdt, W Fiers.   

Abstract

The selective cytotoxic activity of tumor necrosis factor (TNF) on many transformed human or murine cell lines is (almost) not species-specific. There are, however, a limited number of biological assay systems such as gene induction in murine thymoma cells and the murine thymocyte proliferation assay, in which recombinant murine (rm) TNF, but not recombinant human (rh) TNF is active. We have now investigated the possible species specificity of the lethality-inducing properties of TNF in the mouse. When administered alone, only rmTNF, but not rhTNF caused lethality. This difference was not due to a different endotoxin contamination or to a different pharmacokinetic behavior. When a sensitizing agent, galactosamine, was added, the species specificity was abolished. We have shown previously that similar conclusions could be drawn for at least some of the antitumor mechanisms of TNF. We conclude that to mimic the two major phenomena caused by endotoxin administration, viz. lethality and antitumor effect, two distinct signals are needed. In mice, rmTNF can provide both, while rhTNF needs another agent (a sensitizer) to cause systemic toxicity. The results are discussed with respect to recent findings showing that, in the mouse, rhTNF can only bind to the TNF-R55 receptor type, while rmTNF can bind both to the TNF-R55 and TNF-R75 receptor types.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1420597

Source DB:  PubMed          Journal:  Lymphokine Cytokine Res        ISSN: 1056-5477


  12 in total

1.  Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs.

Authors:  Christian O Simon; Christof K Seckert; Doris Dreis; Matthias J Reddehase; Natascha K A Grzimek
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Generation of a mouse tumor necrosis factor mutant with antiperitonitis and desensitization activities comparable to those of the wild type but with reduced systemic toxicity.

Authors:  R Lucas; B Echtenacher; E Sablon; P Juillard; S Magez; J Lou; Y Donati; F Bosman; A Van de Voorde; L Fransen; D N Männel; G E Grau; P de Baetselier
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

3.  Increased release of the tumour necrosis factor receptor p75 by immortalized human keratinocytes results from an activated shedding mechanism and is not related to augmented steady-state levels of p75 mRNA.

Authors:  P Neuner; M Pourmojib; G Klosner; F Trautinger; R Knobler
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

4.  Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration.

Authors:  M R Slowik; L G De Luca; W Fiers; J S Pober
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

5.  Effects of cytokines and infections on brain neurochemistry.

Authors:  Adrian J Dunn
Journal:  Clin Neurosci Res       Date:  2006-08

6.  Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation.

Authors:  Sofie Vandevyver; Lien Dejager; Tom Van Bogaert; Anna Kleyman; Yusen Liu; Jan Tuckermann; Claude Libert
Journal:  J Clin Invest       Date:  2012-05-15       Impact factor: 14.808

7.  Dissociation of TNF-alpha cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selective TNF-alpha mutants.

Authors:  J A Barbara; W B Smith; J R Gamble; X Van Ostade; P Vandenabeele; J Tavernier; W Fiers; M A Vadas; A F Lopez
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

8.  Protection by alpha 1-acid glycoprotein against tumor necrosis factor-induced lethality.

Authors:  C Libert; P Brouckaert; W Fiers
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

9.  Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor.

Authors:  N Takahashi; W Waelput; Y Guisez
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

10.  Enhancement of experimental metastasis by tumor necrosis factor.

Authors:  P Orosz; B Echtenacher; W Falk; J Rüschoff; D Weber; D N Männel
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.